Loss of TDP-43 function underlies hippocampal and cortical synaptic deficits in TDP-43 proteinopathies

[1]  S. Antonyuk,et al.  Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases , 2020, iScience.

[2]  M. di Luca,et al.  Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity , 2020, International journal of molecular sciences.

[3]  Seiji Watanabe,et al.  ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration , 2020, Molecular Brain.

[4]  A. Rodal,et al.  TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression , 2019, Proceedings of the National Academy of Sciences.

[5]  M. Khanna,et al.  Structural Insights Into TDP-43 and Effects of Post-translational Modifications , 2019, Front. Mol. Neurosci..

[6]  C. Jack,et al.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.

[7]  A. Walker,et al.  The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD , 2019, Front. Neurosci..

[8]  Trees-Juen Chuang,et al.  Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons , 2019, Acta neuropathologica communications.

[9]  Timothy A. Miller,et al.  Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia , 2019, bioRxiv.

[10]  A. Girdhar,et al.  Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis , 2019, Front. Mol. Neurosci..

[11]  F. Rigo,et al.  Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration , 2018, Nature Neuroscience.

[12]  Michael J. Steinbaugh,et al.  ALS IMPLICATED PROTEIN TDP-43 SUSTAINS LEVELS OF STMN2 A MEDIATOR OF MOTOR NEURON GROWTH AND REPAIR , 2019, Nature Neuroscience.

[13]  N. Shneider,et al.  Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS. , 2019, Cell reports.

[14]  S. Kurtz,et al.  TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease , 2018, Nucleic acids research.

[15]  W. Lu,et al.  How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition? , 2018, Brain Science Advances.

[16]  Eric T. Wang,et al.  Mice with endogenous TDP‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis , 2018, The EMBO journal.

[17]  Matthew A. White,et al.  1 TDP-43 gains function due to perturbed autoregulation in a Tardbp knockin mouse model of ALS-FTD , 2019 .

[18]  A. Rodal,et al.  TDP-43 misexpression causes defects in dendritic growth , 2017, Scientific Reports.

[19]  Lin Guo,et al.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies. , 2017, Cold Spring Harbor perspectives in medicine.

[20]  G. Bloom,et al.  Extracellular Tau Oligomers Induce Invasion of Endogenous Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction. , 2017, Journal of Alzheimer's disease : JAD.

[21]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[22]  Jeannie Chew,et al.  The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo , 2016, Brain Research.

[23]  E. Buratti,et al.  TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5′UTR , 2016, Brain Research.

[24]  Daniel Hornburg,et al.  TDP‐43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons , 2016, The EMBO journal.

[25]  Krishna B S Swamy,et al.  Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP , 2016, Acta Neuropathologica.

[26]  Benjamin D. Sellers,et al.  Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function , 2016, Neuron.

[27]  Jennifer L. Whitwell,et al.  Updated TDP-43 in Alzheimer’s disease staging scheme , 2016, Acta Neuropathologica.

[28]  S. Leurgans,et al.  Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease , 2015, Annals of neurology.

[29]  C. Broeckhoven,et al.  Functional complementation in Drosophila to predict the pathogenicity of TARDBP variants: evidence for a loss-of-function mechanism , 2015, Neurobiology of Aging.

[30]  E. Buratti.  Functional Significance of TDP-43 Mutations in Disease. , 2015, Advances in genetics.

[31]  J. Kaminker,et al.  Activity-Induced Nr4a1 Regulates Spine Density and Distribution Pattern of Excitatory Synapses in Pyramidal Neurons , 2014, Neuron.

[32]  C. Jack,et al.  TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.

[33]  P. Callaerts,et al.  TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? , 2014, Trends in molecular medicine.

[34]  Chunxing Yang,et al.  TDP-43—The key to understanding amyotrophic lateral sclerosis , 2014, Rare diseases.

[35]  M. Murray,et al.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A , 2014, Acta Neuropathologica.

[36]  Robert V Farese,et al.  Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations , 2013, PloS one.

[37]  C. van Broeckhoven,et al.  Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders , 2013, Human molecular genetics.

[38]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[39]  Pradeep J. Nathan,et al.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[40]  Leonard Petrucelli,et al.  The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation , 2013, Human molecular genetics.

[41]  C. van Broeckhoven,et al.  Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice , 2013, Molecular Neurobiology.

[42]  Gene W. Yeo,et al.  ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 , 2013, Proceedings of the National Academy of Sciences.

[43]  R. Nicoll,et al.  Diversity in NMDA Receptor Composition , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[44]  K. Yamanaka,et al.  Accelerated Disease Onset with Stabilized Familial Amyotrophic Lateral Sclerosis (ALS)-linked Mutant TDP-43 Proteins , 2012, The Journal of Biological Chemistry.

[45]  P. Kind,et al.  The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults , 2012, Neuron.

[46]  V. Meininger,et al.  Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations , 2012, Neurology.

[47]  G. Köhr,et al.  Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function , 2012, Neuropharmacology.

[48]  J. Trojanowski,et al.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration , 2011, Nature Reviews Neuroscience.

[49]  J. Trojanowski,et al.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. , 2011, Trends in molecular medicine.

[50]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[51]  Gene W. Yeo,et al.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 , 2011, Nature Neuroscience.

[52]  D. Dickson,et al.  TDP-43 in aging and Alzheimer's disease - a review. , 2011, International journal of clinical and experimental pathology.

[53]  E. Masliah,et al.  A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.

[54]  John Q. Trojanowski,et al.  TAR DNA-binding protein 43 in neurodegenerative disease , 2010, Nature Reviews Neurology.

[55]  G. Rouleau,et al.  Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. , 2010, Human molecular genetics.

[56]  R. Chitta,et al.  Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. , 2010, Journal of proteome research.

[57]  S. Jiang,et al.  TDP‐43, a neuro‐pathosignature factor, is essential for early mouse embryogenesis , 2009, Genesis.

[58]  K. Sleegers,et al.  Contribution of TARDBP to Alzheimer's disease genetic etiology. , 2010, Journal of Alzheimer's disease : JAD.

[59]  N. Cairns,et al.  TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration , 2009, Proceedings of the National Academy of Sciences.

[60]  John Q Trojanowski,et al.  Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. , 2009, Human molecular genetics.

[61]  Yubing Lu,et al.  Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching , 2009, Molecular Brain.

[62]  G. Schellenberg,et al.  A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitro , 2008, FEBS letters.

[63]  Isabelle M. Mansuy,et al.  Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease , 2008, Molecular Neurobiology.

[64]  J. Trojanowski,et al.  TDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis , 2007, Neurosignals.

[65]  J. Trojanowski,et al.  TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. , 2007, Archives of neurology.

[66]  J. Trojanowski,et al.  TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease , 2007, Acta Neuropathologica.

[67]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[68]  R. Malinow,et al.  NMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII , 2005, Neuron.

[69]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[70]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[71]  Richard F. Thompson,et al.  Importance of the Intracellular Domain of NR2 Subunits for NMDA Receptor Function In Vivo , 1998, Cell.

[72]  S. Nakanishi,et al.  Differential expression of five N‐methyl‐D‐aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats , 1994, The Journal of comparative neurology.